119 related articles for article (PubMed ID: 11173905)
21. Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6.
Daig R; Rogler G; Aschenbrenner E; Vogl D; Falk W; Gross V; Schölmerich J; Andus T
Gut; 2000 Mar; 46(3):350-8. PubMed ID: 10673296
[TBL] [Abstract][Full Text] [Related]
22. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis.
Tsukada Y; Nakamura T; Iimura M; Iizuka BE; Hayashi N
Am J Gastroenterol; 2002 Nov; 97(11):2820-8. PubMed ID: 12425554
[TBL] [Abstract][Full Text] [Related]
23. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis.
Bioque G; Bouma G; Crusius JB; Koutroubakis I; Kostense PJ; Meuwissen SG; Peña AS
Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):105-10. PubMed ID: 8723412
[TBL] [Abstract][Full Text] [Related]
24. Study of cytokines in ulcerative colitis.
Funakoshi K; Sugimura K; Sasakawa T; Bannai H; Anezaki K; Ishizuka K; Yoshida K; Narisawa R; Asakura H
J Gastroenterol; 1995 Nov; 30 Suppl 8():61-3. PubMed ID: 8563893
[TBL] [Abstract][Full Text] [Related]
25. Correlations between interleukin-8, and myeloperoxidase or luminol-dependent chemiluminescence in inflamed mucosa of ulcerative colitis.
Anezaki K; Asakura H; Honma T; Ishizuka K; Funakoshi K; Tsukada Y; Narisawa R
Intern Med; 1998 Mar; 37(3):253-8. PubMed ID: 9617859
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease.
Cominelli F; Pizarro TT
Aliment Pharmacol Ther; 1996; 10 Suppl 2():49-53; discussion 54. PubMed ID: 8899101
[TBL] [Abstract][Full Text] [Related]
27. [Intelukin-10 expression with immunorreglatory function in the mucosa of patients with ulcerative colitis].
Fonseca-Camarillo G; Furuzawa-Carballeda J; Martínez-Benítez B; Barreto-Zúñiga R; Yamamoto-Furusho K
Rev Gastroenterol Mex; 2011; 76(2):113-9. PubMed ID: 21724486
[TBL] [Abstract][Full Text] [Related]
28. Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease.
Brynskov J; Tvede N; Andersen CB; Vilien M
Gut; 1992 Jan; 33(1):55-8. PubMed ID: 1740278
[TBL] [Abstract][Full Text] [Related]
29. Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD).
Dionne S; D'Agata ID; Hiscott J; Vanounou T; Seidman EG
Clin Exp Immunol; 1998 Jun; 112(3):435-42. PubMed ID: 9649212
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance and assessment of cytokines in various stages of ulcerative colitis.
Zou K; Liu S; Xie X; Yi C
J Tongji Med Univ; 2001; 21(4):308-9. PubMed ID: 12539555
[TBL] [Abstract][Full Text] [Related]
31. IL-10-- and IL-20--expressing epithelial and inflammatory cells are increased in patients with ulcerative colitis.
Fonseca-Camarillo G; Furuzawa-Carballeda J; Llorente L; Yamamoto-Furusho JK
J Clin Immunol; 2013 Apr; 33(3):640-8. PubMed ID: 23207823
[TBL] [Abstract][Full Text] [Related]
32. MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis.
Pathak S; Grillo AR; Scarpa M; Brun P; D'Incà R; Nai L; Banerjee A; Cavallo D; Barzon L; Palù G; Sturniolo GC; Buda A; Castagliuolo I
Exp Mol Med; 2015 May; 47(5):e164. PubMed ID: 25998827
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
[TBL] [Abstract][Full Text] [Related]
34. Expression of IL-8, TNF-alpha and IFN-gamma m-RNA in ulcerative colitis, particularly in patients with inactive phase.
Masuda H; Iwai S; Tanaka T; Hayakawa S
J Clin Lab Immunol; 1995; 46(3):111-23. PubMed ID: 8926619
[TBL] [Abstract][Full Text] [Related]
35. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J
Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866
[TBL] [Abstract][Full Text] [Related]
36. In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii.
Ricci S; Macchia G; Ruggiero P; Maggi T; Bossù P; Xu L; Medaglini D; Tagliabue A; Hammarström L; Pozzi G; Boraschi D
BMC Biotechnol; 2003 Sep; 3():15. PubMed ID: 13129437
[TBL] [Abstract][Full Text] [Related]
37. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon.
Keshavarzian A; Fusunyan RD; Jacyno M; Winship D; MacDermott RP; Sanderson IR
Am J Gastroenterol; 1999 Mar; 94(3):704-12. PubMed ID: 10086655
[TBL] [Abstract][Full Text] [Related]
38. MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis.
Haga K; Chiba A; Shibuya T; Osada T; Ishikawa D; Kodani T; Nomura O; Watanabe S; Miyake S
J Gastroenterol Hepatol; 2016 May; 31(5):965-72. PubMed ID: 26590105
[TBL] [Abstract][Full Text] [Related]
39. Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10.
Chomarat P; Vannier E; Dechanet J; Rissoan MC; Banchereau J; Dinarello CA; Miossec P
J Immunol; 1995 Feb; 154(3):1432-9. PubMed ID: 7822808
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease.
Fonseca-Camarillo G; Furuzawa-Carballeda J; Yamamoto-Furusho JK
Cytokine; 2015 Oct; 75(2):389-402. PubMed ID: 26141420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
